AI in Drug Discovery
Jorge discusses the multifaceted role of AI in drug discovery, emphasizing its potential to enhance early detection and treatment of diseases like lung cancer. Greg highlights the importance of integrating biomarkers and AI-powered imaging techniques to improve patient outcomes, particularly in identifying cancer variants. The conversation reveals the transformative potential of AI in both early and late-stage clinical trials, paving the way for more effective therapies.In this clip
From this podcast
Raising Health
Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Related Questions